Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2026-02-24 @ 5:58 PM
Study NCT ID:
NCT04137120
Status:
COMPLETED
Last Update Posted:
2023-02-17
First Post:
2019-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice
Sponsor:
Bayer
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Retinal Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Aflibercept | View |
| None | Intravitreal injection | View |
| None | Ocular disease | View |
| None | Wet age-related macular degeneration (wAMD) | View |
| None | Diabetic macular edema (DME) | View |
| None | Macular edema secondary to central retinal vein occlusion (CRVO) | View |
| None | Macular edema secondary to branch retinal vein occlusion (BRVO) | View |
| None | Myopic choroidal neovascularization (mCNV) | View |
| None | Mexico | View |